Literature DB >> 33615474

Hsa_circ_0102171 aggravates the progression of cervical cancer through targeting miR-4465/CREBRF axis.

Xi Tang1, Xiaomin Wen1, Zhouyu Li1, Danxia Wen1, Ling Lin1, Jinquan Liu1, Mingyi Li1.   

Abstract

Cervical cancer (CC) has caused numerous cancer-related deaths in women. Recent years, circular RNAs have been reported as vital factors in CC tumorigenesis. Our current study focused on the role of hsa_circ_0102171 (called circ_0102171 subsequently) in CC. At first, we applied reverse transcription polymerase chain reaction to detect the expression of circ_0102171 in CC tissues and cells. Subsequently, we silenced circ_0102171 to conduct loss-of-function assays, including cell counting kit-8 assay, 5-ethynyl-2'-deoxyuridine staining, Transwell assay, and flow cytometry analysis. Interestingly, we discovered that circ_0102171 expressed at a high level in CC tissues and cells. Functionally, silencing circ_0102171 prohibited cell proliferation, migration and invasion, and strengthened cell apoptosis in CC in vitro. Mechanistic investigations revealed that circ_0102171 could act as a sponge for miR-4465. Gain-of-function assays demonstrated that miR-4465 hindered the growth and migration of CC cells. Moreover, circ_0102171 enhanced the level of CREB3 regulatory factor (CREBRF) which was the downstream target of miR-4465. Rescue assays suggested that CREBRF and miR-4465 could involve in circ_0102171-mediated CC progression. Finally, in vivo data supported that silencing circ_0102171 hindered CC cell growth. In conclusion, circ_0102171 aggravates CC progression via targeting miR-4465/CREBRF axis.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  CREBRF; cervical cancer; hsa_circ_0102171; miR-4465

Year:  2020        PMID: 33615474     DOI: 10.1002/jcp.30210

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injury.

Authors:  Charlotte Sarre; Rafael Contreras-Lopez; Farida Djouad; Stéphanie Barrere-Lemaire; Nitirut Nernpermpisooth; Christian Barrere; Sarah Bahraoui; Claudia Terraza; Gautier Tejedor; Anne Vincent; Patricia Luz-Crawford; Kantapich Kongpol; Sarawut Kumphune; Christophe Piot; Joel Nargeot; Christian Jorgensen
Journal:  Stem Cell Res Ther       Date:  2022-04-23       Impact factor: 8.079

2.  LncRNA SNHG16 regulates trophoblast functions by the miR-218-5p/LASP1 axis.

Authors:  Zhou Yu; Yulei Zhang; Haoyu Zheng; Qiong Gao; Haidong Wang
Journal:  J Mol Histol       Date:  2021-06-10       Impact factor: 2.611

Review 3.  Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes.

Authors:  Harpinder Kaur; Nishant Shekhar; Saurabh Sharma; Phulen Sarma; Ajay Prakash; Bikash Medhi
Journal:  Pharmacol Rep       Date:  2021-01-03       Impact factor: 3.024

4.  Genome-Wide Identification of CircRNAs of Infective Larvae and Adult Worms of Parasitic Nematode, Haemonchus contortus.

Authors:  Caixian Zhou; Yao Zhang; Simin Wu; Zhiheng Wang; Waresi Tuersong; Chunqun Wang; Feng Liu; Min Hu
Journal:  Front Cell Infect Microbiol       Date:  2021-11-22       Impact factor: 5.293

5.  PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model.

Authors:  Shiwen Peng; Marietta Tan; Yen-Der Li; Max A Cheng; Emily Farmer; Louise Ferrall; Stephanie Gaillard; Richard B S Roden; Chien-Fu Hung; T-C Wu
Journal:  Cancer Immunol Immunother       Date:  2020-10-27       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.